Bio Green Med Solution, Inc. (BGMS) vs Kairos Pharma, Ltd. (KAPA)

Bio Green Med Solution, Inc. and Kairos Pharma, Ltd. are both Biotechnology companies. Bio Green Med Solution, Inc. and Kairos Pharma, Ltd. are of similar size ($6.2M and $6.1M). Kairos Pharma, Ltd. has the higher net margin (0.00% vs −715.5%) and the lower return on invested capital (−322.9% vs −67.3%). Across the 12 metrics below, Kairos Pharma, Ltd. leads on 7 and Bio Green Med Solution, Inc. on 5.

Valuation

Metric BGMS KAPA Biotechnology median
P/E n/m n/m 7.88
P/S 2.77 n/m 11.47
P/B 0.72 1.26 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 0.73 n/m 10.73
Earnings yield (395.65%) (113.92%) (28.84%)
Free cash flow yield (19.45%) (75.40%) (23.03%)

Profitability

Metric BGMS KAPA Biotechnology median
Gross margin 19.34% — 65.16%
Operating margin (194.95%) 0.00% 0.00%
Net margin (715.48%) 0.00% 0.00%
Free cash flow margin (59.00%) 0.00% 0.00%
Return on equity (246.85%) (113.96%) (57.72%)
Return on assets (217.30%) (104.32%) (49.22%)
Return on invested capital (67.28%) (322.91%) 0.00%

Growth

Metric BGMS KAPA Biotechnology median
Revenue growth (TTM) 2,414.86% — 5.64%
EPS growth (last fiscal year) 98.71% (30.44%) —
Revenue growth, 5-year CAGR (17.41%) — 8.40%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric BGMS KAPA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.63 11.98 4.73
Net debt to EBITDA 0.42 1.65 0.96

Dividend

Metric BGMS KAPA Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric BGMS KAPA Biotechnology median
Market cap 6.16m 6.13m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack